UroCareLive

CME Presentations

Overactive Bladder Management: Updates for Primary Care and Specialists


Presentations


Speakers

  • Matt T. Rosenberg, MD

    Matt T. Rosenberg, MD

    Matt T. Rosenberg, MD

    Medical Director

    Matt T. Rosenberg, MD, is the medical director of Mid-Michigan Health Centers and is on staff at Allegiance Health (both located in Jackson) where he served as the chief of the Department of Family Medicine from 2003–2006. Dr Rosenberg has a special interest in the medical management of urologic diseases. He has authored/coauthored articles published in peer-reviewed journals such as the International Journal of Clinical Practice, Journal of Urology, and Urology. He is the section editor of urology for the International Journal of Clinical Practice, a reviewer for various national and international journals, and is the coordinator of primary care education for the American Urological Association Office of Education. He earned his medical degree at the University of California, Irvine.
  • Diane K. Newman, DNP, ANP-BC, BCB-PMD, FAAN

    Diane K. Newman, DNP, ANP-BC, BCB-PMD, FAAN

    Diane K. Newman, DNP, ANP-BC, BCB-PMD, FAAN

    Adjunct Professor of Urology in Surgery

    Diane K. Newman, DNP, ANP-BC, BCB-PMD, FAAN, is Research Investigator Senior and Adjunct Associate Professor of Urology in Surgery at the Perelman School of Medicine, University of Pennsylvania, and Co-Director of the Penn Center for Continence and Pelvic Health, Division of Urology, University of Pennsylvania Medical Center, both in Philadelphia. Dr Newman evaluates, treats, and manages individuals with bladder and pelvic floor disorders using biofeedback and catheters and other devices to manage bladder dysfunction. She is involved in federally-funded research, has held leadership positions in professional groups and government-sponsored expert panels, and has co-authored several books and medical publications. She received her DNP from Thomas Jefferson University in Philadelphia.
  • Scott A. MacDiarmid, MD, FRCPSC

    Scott A. MacDiarmid, MD, FRCPSC

    Scott A. MacDiarmid, MD, FRCPSC

    Director

    Scott A. MacDiarmid, MD, is director of the Alliance Urology Specialists Bladder Control and Pelvic Pain Center in Greensboro, North Carolina, and is a clinical professor in the Department of Urology, University of North Carolina, Chapel Hill. Dr MacDiarmid’s clinical, educational and academic expertise is in male and female voiding dysfunction, neurogenic bladder, and complex lower urinary tract and pelvic floor reconstruction. He has authored or co-authored numerous books, book chapters and journal articles, and is recognized nationwide as a leader in his field. He completed fellowships in reconstructive urology and urodynamics at Duke University Medical Center in Durham, North Carolina, the University of Otago in Christchurch, New Zealand, and the University of Sheffield in England.
  • David R. Staskin, MD

    David R. Staskin, MD

    David R. Staskin, MD

    Associate Professor of Urology

    David R. Staskin, MD, is associate professor of urology at Tufts University School of Medicine and director of the Center for Male and Female Pelvic Health at St. Elizabeth’s Medical Center in Boston, Massachusetts. After completing his urology residency at the Hospital of the University of Pennsylvania, NKF fellowship in uropharmacology, and reconstructive pelvic surgery fellowship at UCLA, Dr Staskin held faculty positions at Boston University, Harvard, and Cornell-Weill Medical Schools. He has published extensively in the areas of male and female lower urinary tract symptoms and surgery, uropharmacology, neurourology, and urodynamics. Dr Staskin is the inventor of Sparc (ArcSP), RetroArc (ArcTV) slings and other surgical products, and holds 67 US/international patents.

CME Information

Overactive Bladder Management: Updates for Primary Care and Specialists


  

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

Managing Overactive Bladder in the Primary Care Setting

  • Differentiate OAB symptoms from other lower urinary tract symptoms
  • Utilize current practice guidelines and discuss the benefits and challenges regarding the current treatment landscape of OAB
  • Employ strategies to mitigate treatment-related side effects, and improve patient adherence and quality of life

Enhancing the Quality of Life for Patients with Overactive Bladder

  • Assess the safety and efficacy of emerging therapies and combinations being explored for the management of OAB
  • Employ strategies to mitigate treatment-related side effects and maintain quality of life for patients with OAB
  • Adopt principles of shared decision-making, including educating patients about their OAB, improving adherence and setting realistic treatment goals

Acknowledgement

This activity is supported by an independent educational grant from Astellas

Tuition

Complimentary

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Live Internet Activity

The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Release/Expiration

Live Activity
  • Managing Overactive Bladder in the Primary Care Setting

Thursday, November 15, 2018 from 11:00am – 12:00pm ET

  • Enhancing the Quality of Life for Patients with Overactive Bladder

Thursday, November 15, 2018 from 12:00pm – 1:00pm EDT

Enduring Material
  • Managing Overactive Bladder in the Primary Care Setting: The enduring material will be available from November 15, 2018 to May 15, 2019.
  • Enhancing the Quality of Life for Patients with Overactive Bladder: The enduring material will be available from November 15, 2018 to May 15, 2019.

Target Audience

Managing Overactive Bladder in the Primary Care Setting: Primary care physicians, internists, family practice physicians, general practitioners, nurse practitioners, physician assistants, pharmacists, and other health care practitioners that care for patients with overactive bladder.

Enhancing the Quality of Life for Patients with Overactive Bladder: Urologists and other health care professionals that specialize in the management of patients with overactive bladder.

Estimated Time to Complete

This activity consists of two sessions which should take approximately 2.0 hours to complete.

Method Of Participation

There are no fees to participate in this activity. To participate in the activity, go to www.urocarelive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Disclosure of Conflict of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Financial Disclosures

Presenters

Matt T. Rosenberg
Consulting Fees: Astellas, Avadel, Ferring

Scott A. MacDiarmid, MD, FRCPSC
Consulting Fees: Astellas, Allergan, Medtronic, Larorie
Fees for Non-CME/CE Services Received Directly from Commercial Interest or their Agents: Astellas, Allergan, Avadel
Contracted Research: Astellas, Allergan

Diane K. Newman, DNP, ANP-BC, BCB-PMD, FAAN
Royalty: Springer
Fees for Non-CME/CE Services Received Directly from Commercial Interest or their Agents: Avadel
Contracted Research: Wellspect, Verathon, GTx

David R. Staskin, MD
Consulting Fees: Astellas, Velicept, Ferring
Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents: Astellas
Contracted Research: Astellas, Velicept, Urovant

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

David Howard, None

The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Alissa Yost, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unapproved/Off Label Use (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMERS

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information

Accreditation Support
Please contact the Postgraduate Institute for Medicine at www.pimed.com

Technical Support
For any technical issues or issues with your CME Certificate, please contact UroCareLive at 877-394-1306 or at Support@UroCareLive.com..